Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Sell
30
IHE Quote, Financials, Valuation and Earnings
Last price:
$66.56
Seasonality move
:
1.02%
Day range:
$65.99 - $66.57
52-week range:
$60.88 - $72.94
Dividend yield:
1.71%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
167.1K
Avg. volume:
62K
1-year change:
9.16%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
$66.56 | -- | -- | -- | $0.21 | 1.71% | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
$66.21 | -- | -- | -- | $0.26 | 1.49% | -- |
|
IYH
iShares US Healthcare ETF
|
$59.05 | -- | -- | -- | $0.20 | 1.23% | -- |
|
PPH
VanEck Pharmaceutical ETF
|
$87.70 | -- | -- | -- | $0.41 | 1.83% | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
$257.03 | -- | -- | -- | $0.92 | 1.51% | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
$139.32 | -- | -- | -- | $0.62 | 1.65% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | 1.040 | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | 1.049 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | 0.983 | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | 0.750 | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | 1.066 | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | 0.981 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- | -- |
iShares US Pharmaceuticals ETF vs. Competitors
-
Which has Higher Returns IHE or FHLC?
Fidelity MSCI Health Care Index ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat Fidelity MSCI Health Care Index ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- -
What do Analysts Say About IHE or FHLC?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity MSCI Health Care Index ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than Fidelity MSCI Health Care Index ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than Fidelity MSCI Health Care Index ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 FHLCFidelity MSCI Health Care Index ETF0 0 0 -
Is IHE or FHLC More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.656, which suggesting that the stock is 34.431% less volatile than S&P 500. In comparison Fidelity MSCI Health Care Index ETF has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.734%.
-
Which is a Better Dividend Stock IHE or FHLC?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.21 per share corresponding to a yield of 1.71%. Fidelity MSCI Health Care Index ETF offers a yield of 1.49% to investors and pays a quarterly dividend of $0.26 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. Fidelity MSCI Health Care Index ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or FHLC?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than Fidelity MSCI Health Care Index ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than Fidelity MSCI Health Care Index ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while Fidelity MSCI Health Care Index ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for Fidelity MSCI Health Care Index ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- --
-
Which has Higher Returns IHE or IYH?
iShares US Healthcare ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About IHE or IYH?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Healthcare ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is IHE or IYH More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.656, which suggesting that the stock is 34.431% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.685, suggesting its less volatile than the S&P 500 by 31.453%.
-
Which is a Better Dividend Stock IHE or IYH?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.21 per share corresponding to a yield of 1.71%. iShares US Healthcare ETF offers a yield of 1.23% to investors and pays a quarterly dividend of $0.20 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IYH?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
-
Which has Higher Returns IHE or PPH?
VanEck Pharmaceutical ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat VanEck Pharmaceutical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- PPHVanEck Pharmaceutical ETF-- -- -- -
What do Analysts Say About IHE or PPH?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Pharmaceutical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than VanEck Pharmaceutical ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than VanEck Pharmaceutical ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 PPHVanEck Pharmaceutical ETF0 0 0 -
Is IHE or PPH More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.656, which suggesting that the stock is 34.431% less volatile than S&P 500. In comparison VanEck Pharmaceutical ETF has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.432%.
-
Which is a Better Dividend Stock IHE or PPH?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.21 per share corresponding to a yield of 1.71%. VanEck Pharmaceutical ETF offers a yield of 1.83% to investors and pays a quarterly dividend of $0.41 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. VanEck Pharmaceutical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or PPH?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than VanEck Pharmaceutical ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than VanEck Pharmaceutical ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while VanEck Pharmaceutical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for VanEck Pharmaceutical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- PPHVanEck Pharmaceutical ETF-- -- -- --
-
Which has Higher Returns IHE or VHT?
Vanguard Health Care Index Fund ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat Vanguard Health Care Index Fund ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- -
What do Analysts Say About IHE or VHT?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Vanguard Health Care Index Fund ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than Vanguard Health Care Index Fund ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than Vanguard Health Care Index Fund ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 VHTVanguard Health Care Index Fund ETF0 0 0 -
Is IHE or VHT More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.656, which suggesting that the stock is 34.431% less volatile than S&P 500. In comparison Vanguard Health Care Index Fund ETF has a beta of 0.708, suggesting its less volatile than the S&P 500 by 29.236%.
-
Which is a Better Dividend Stock IHE or VHT?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.21 per share corresponding to a yield of 1.71%. Vanguard Health Care Index Fund ETF offers a yield of 1.51% to investors and pays a quarterly dividend of $0.92 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. Vanguard Health Care Index Fund ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or VHT?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than Vanguard Health Care Index Fund ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than Vanguard Health Care Index Fund ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while Vanguard Health Care Index Fund ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for Vanguard Health Care Index Fund ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- --
-
Which has Higher Returns IHE or XLV?
Health Care Select Sector SPDR Fund has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat Health Care Select Sector SPDR Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- -
What do Analysts Say About IHE or XLV?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Health Care Select Sector SPDR Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than Health Care Select Sector SPDR Fund, analysts believe iShares US Pharmaceuticals ETF is more attractive than Health Care Select Sector SPDR Fund.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 XLVHealth Care Select Sector SPDR Fund0 0 0 -
Is IHE or XLV More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.656, which suggesting that the stock is 34.431% less volatile than S&P 500. In comparison Health Care Select Sector SPDR Fund has a beta of 0.672, suggesting its less volatile than the S&P 500 by 32.764%.
-
Which is a Better Dividend Stock IHE or XLV?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.21 per share corresponding to a yield of 1.71%. Health Care Select Sector SPDR Fund offers a yield of 1.65% to investors and pays a quarterly dividend of $0.62 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. Health Care Select Sector SPDR Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or XLV?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than Health Care Select Sector SPDR Fund quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than Health Care Select Sector SPDR Fund's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while Health Care Select Sector SPDR Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for Health Care Select Sector SPDR Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
